Details for New Drug Application (NDA): 021583
✉ Email this page to a colleague
The generic ingredient in DEPO-SUBQ PROVERA 104 is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 021583
Tradename: | DEPO-SUBQ PROVERA 104 |
Applicant: | Pfizer |
Ingredient: | medroxyprogesterone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 021583
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DEPO-SUBQ PROVERA 104 | medroxyprogesterone acetate | INJECTABLE;SUBCUTANEOUS | 021583 | NDA | Pharmacia & Upjohn Company LLC | 0009-4709 | 0009-4709-13 | 1 SYRINGE in 1 CARTON (0009-4709-13) / .65 mL in 1 SYRINGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | 104MG/0.65ML | ||||
Approval Date: | Dec 17, 2004 | TE: | RLD: | Yes |
Expired US Patents for NDA 021583
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | DEPO-SUBQ PROVERA 104 | medroxyprogesterone acetate | INJECTABLE;SUBCUTANEOUS | 021583-001 | Dec 17, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription